Problems of using artificial intelligence technologies in clinical drug research

The use of artificial intelligence (AI) technologies in clinical trials (CT) of medicines has led to a significant reduction in time and financial costs for the development of new medicines. However, their widespread adoption faces a number of unresolved issues related to data quality, regulation, e...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	K. N. Sorokina, N. Yu. Chernus, V. Yu. Usov, A. A. Tulupov
Format:	Artigo
Sprog:	Russo
Udgivet:	Russian Academy of Sciences, Siberian Branch Publishing House 2026-03-01
Serier:	Сибирский научный медицинский журнал
Fag:	artificial intelligence clinical research machine learning digital twin synthetic control regulation personalized medicine
Online adgang:	https://sibmed.elpub.ru/jour/article/view/2725
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!